Related Experiment Video
Updated: Jul 6, 2026

28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
p53 expression and K-ras mutation in colorectal adenomas
Gut
|May 1, 1993
Summary
Investigating colorectal adenomas revealed K-ras mutations in 27% of cases. While p53 overexpression and K-ras mutations cooperate in vitro, their combined presence in benign polyps is insufficient for malignant transformation in vivo.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Colorectal adenomas are precursor lesions to colorectal cancer.
- Understanding the molecular events driving malignant transformation is crucial for early detection and prevention.
- The roles of p53 and K-ras mutations in colorectal tumorigenesis are of significant interest.
Purpose of the Study:
- To investigate the frequency of p53 overexpression and K-ras codon 12 mutations in colorectal adenomas.
- To explore the cooperative effect of mutant p53 and ras genes in cellular transformation.
- To assess whether the combined presence of p53 overexpression and K-ras mutation is sufficient for malignant transformation of colorectal adenomas in vivo.
Main Methods:
- Immunohistochemistry was used to detect p53 overexpression in colorectal adenomas.
- K-ras codon 12 mutations were identified using molecular techniques.
- In vitro transformation assays were performed using primary rat cells transfected with mutant p53 and ras genes.
Main Results:
- p53 overexpression was detected in only 5% of the investigated colorectal adenomas.
- K-ras codon 12 mutations were found in 8 out of 30 (27%) adenomas examined.
- In vitro studies demonstrated that mutant p53 and ras genes cooperate to transform primary rat cells into a tumourigenic cell line.
Conclusions:
- The combination of p53 overexpression and K-ras mutation in a benign tubulovillous polyp was observed.
- This specific combination of molecular events appears insufficient to induce malignant transformation of a large bowel adenoma in vivo.
- Further research is needed to elucidate the complete molecular pathways involved in colorectal adenoma progression to cancer.
Related Concept Videos
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:

